Entropy Solutions Adds Two to Board of Advisors

Rafik Bishara, Ph.D., and Jack McGuire to advise on pharmaceutical, biologics and blood industry issues

 MINNEAPOLIS — May 7, 2008 — Entropy Solutions Inc., a thermal technology development company, today announced two additions to its Board of Advisors: Dr. Rafik Bishara and Jack McGuire. Dr. Bishara is chairman of the Pharmaceutical Cold Chain Interest Group (PCCIG), Parenteral Drug Association (PDA), and will advise Entropy on issues related to cold chain management and best practices in temperature control of life science products. Mr. McGuire is the former president and chief executive officer (CEO) of the American Red Cross, and will advise Entropy on issues surrounding the blood and plasma industry (see complete biographies below).

 “I am impressed with the quality of Entropy Solutions’ product, GREENBOX, which is supported by credible data,” Dr. Bishara said. “By making GREENBOX reusable, Entropy is delivering on its mission of protecting our environment both now and in the future.”

 “Entropy’s phase change technology has huge potential for issues related to critical, high-value materials like blood and vaccines,” Mr. McGuire said. “Companies in these industries have been looking for a solution like GREENBOX for years now, and are responding positively.”

 “Rafik and Jack are highly esteemed experts in their respective industries, and we are honored to have them join our Board of Advisors,” said Eric Lindquist, president of Entropy Solutions. “They will provide us with expertise in our key markets – pharmaceutical, biologics and blood supplies – which will in turn strengthen our company for years to come.”

About Rafik Bishara

Rafik H. Bishara, Ph.D., is the current chairman of the Pharmaceutical Cold Chain Interest Group (PCCIG), Parenteral Drug Association (PDA). Dr. Bishara was a member of the Board of Directors for Sensitech Inc. from 2005-2006, when it was acquired by Carrier Corporation, and continues to serve as a technical advisor today. He also serves on the Board of Directors for Kodiak Thermal Technologies, Inc., as a temporary advisor to the World Health Organization (WHO), and on the Editorial Advisory Board of American Pharmaceutical Outsourcing Journal. Dr. Bishara is the recipient of the PDA’s 2007 Distinguished Service Award, the IQPC’s 2008 award for Most Significant Contribution to Cold Chain Excellence, and the School of Health Sciences, Purdue University, 2008 Distinguished Alumnus Award. Recently, Dr. Bishara retired from his position as director of Quality Knowledge Management and Technical Support at Eli Lilly and Company after a 35-year career.

About Jack McGuire

Jack McGuire is currently an adjunct professor at Dartmouth College, and most recently served as president and CEO of the American Red Cross. Previously, McGuire was president of Whatman Filtration Products and president, CEO and director of Hemasure Blood Filtration Products. He is currently a board member for several organizations, including the National Blood Foundation Trust Fund, LEK Consulting, Cambridge Heart, Twin Pines Housing Trust and the Somali Mam Foundation, and also performs consulting work for Insigniam Performance. McGuire holds a MBA from Harvard University and is a retired Captain from the United States Maine Corps.

To learn more about Entropy Solutions and their GREENBOX Thermal Management System, please visit www.entropysolutionsinc.com, www.GREENBOXsystems.com or call 1-877-4GRNBOX. 

About Entropy Solutions Inc.

Entropy Solutions Inc. (www.entropysolutionsinc.com) is a thermal technology development company with its global offices based in Minneapolis, Minn. The company’s mission is to provide innovative, cost-effective, temperature-controlled solutions for the transport and distribution of temperature-sensitive products throughout the world. Entropy Solutions’ GREENBOX™ technology is an innovative and next-generation passive thermal breakthrough in cost-effective, highly efficient shipping containers. Using patented phase-change technology, the system is capable of maintaining narrow temperature ranges for record durations. The company’s primary focus is the life science industry, where the ability to maintain global regulators mandated temperatures during the transport and delivery of temperature-sensitive pharmaceuticals, biologics and blood products are crucial to saving lives and advancing medical discoveries.